Evidence map›Paper›PMID 34068712›Full record

SynthesisCells2021

LN-Derived Fibroblastic Reticular Cells and Their Impact on T Cell Response-A Systematic Review.

Bianca O Ferreira, Lionel F Gamarra, Mariana P Nucci, Fernando A Oliveira, Gabriel N A Rego, Luciana Marti

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bianca O FerreiraDepartment of Experimental Research, Hospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.ORCID 0000-0002-1508-090X
Lionel F GamarraDepartment of Experimental Research, Hospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.
Mariana P NucciDepartment of Experimental Research, Hospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.ORCID 0000-0002-1502-9215
Fernando A OliveiraDepartment of Experimental Research, Hospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.ORCID 0000-0002-7226-1694
Gabriel N A RegoDepartment of Experimental Research, Hospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.
Luciana MartiDepartment of Experimental Research, Hospital Israelita Albert Einstein, São Paulo 05652-000, Brazil.ORCID 0000-0002-3890-0827
Hospital Israelita Albert Einstein · BR

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/14836-6 and 2018/00094-9Sistema Nacional de Laboratórios em Nanotecnologias (SisNANO) - Ministério da Ciência e Tecnologia e Inovação 2019
6 · The paper itself

Abstract

Fibroblastic reticular cells (FRCs), usually found and isolated from the T cell zone of lymph nodes, have recently been described as much more than simple structural cells. Originally, these cells were described to form a conduit system called the "reticular fiber network" and for being responsible for transferring the lymph fluid drained from tissues through afferent lymphatic vessels to the T cell zone. However, nowadays, these cells are described as being capable of secreting several cytokines and chemokines and possessing the ability to interfere with the immune response, improving it, and also controlling lymphocyte proliferation. Here, we performed a systematic review of the several methods employed to investigate the mechanisms used by fibroblastic reticular cells to control the immune response, as well as their ability in determining the fate of T cells. We searched articles indexed and published in the last five years, between 2016 and 2020, in PubMed, Scopus, and Cochrane, following the PRISMA guidelines. We found 175 articles published in the literature using our searching strategies, but only 24 articles fulfilled our inclusion criteria and are discussed here. Other articles important in the built knowledge of FRCs were included in the introduction and discussion. The studies selected for this review used different strategies in order to access the contribution of FRCs to different mechanisms involved in the immune response: 21% evaluated viral infection in this context, 13% used a model of autoimmunity, 8% used a model of GvHD or cancer, 4% used a model of Ischemic-reperfusion injury (IRI). Another four studies just targeted a particular signaling pathway, such as MHC II expression, FRC microvesicles, FRC secretion of IL-15, FRC network, or ablation of the lysophosphatidic acid (LPA)-producing ectoenzyme autotaxin. In conclusion, our review shows the strategies used by several studies to isolate and culture fibroblastic reticular cells, the models chosen by each one, and dissects their main findings and implications in homeostasis and disease.

Indexed as

AnimalsAutoimmunityCell ProliferationCytokinesFibroblastsHomeostasisHumansImmunophenotypingLymphLymphatic VesselsLymph NodesLymphocytesLysophospholipidsMiceMice, Inbred C57BLMice, Inbred NODCytokineslysophosphatidic acidLysophospholipidsReticulinfibroblastic reticular cellslymph nodesT cells

Identifiers

PMID34068712
PMCPMC8151444
OpenAlexW3162759720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.